Ghost-Managed Medicine : Big Pharma’s Invisible Hands / / Sergio Sismondo.
Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | Manchester : : Mattering Press,, [2018] ©[2018] |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (231 pages) :; illustrations ; |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544390204498 |
---|---|
ctrlnum |
(CKB)5590000000430781 (OCoLC)1229912820 (MdBmJHUP)muse95583 (oapen)https://directory.doabooks.org/handle/20.500.12854/48607 (EXLCZ)995590000000430781 |
collection |
bib_alma |
record_format |
marc |
spelling |
Sismondo, Sergio, author. Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo. Mattering Press 2018 Manchester : Mattering Press, [2018] ©[2018] 1 online resource (231 pages) : illustrations ; text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on print version record. Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this ‘assemblage marketing’ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed – or ‘political economies of knowledge’ – and not just about truth and falsity of medical knowledge. In pharmaceutical companies’ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companies’ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctors’ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharma’s many invisible hands are busy throughout medicine, and medicine changes as a result. English Pharmaceutical industry Moral and ethical aspects. fast (OCoLC)fst01060163 Drugs Research Moral and ethical aspects. fast (OCoLC)fst00898905 Drugs Marketing Moral and ethical aspects. fast (OCoLC)fst00898841 Drugs Research Moral and ethical aspects. Drugs Marketing Moral and ethical aspects. Pharmaceutical industry Influence. Pharmaceutical industry Moral and ethical aspects. Electronic books. Medicine (General) 0-9955277-8-4 |
language |
English |
format |
eBook |
author |
Sismondo, Sergio, |
spellingShingle |
Sismondo, Sergio, Ghost-Managed Medicine Big Pharma’s Invisible Hands / |
author_facet |
Sismondo, Sergio, |
author_variant |
s s ss |
author_role |
VerfasserIn |
author_sort |
Sismondo, Sergio, |
title |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / |
title_sub |
Big Pharma’s Invisible Hands / |
title_full |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo. |
title_fullStr |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo. |
title_full_unstemmed |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / Sergio Sismondo. |
title_auth |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / |
title_new |
Ghost-Managed Medicine |
title_sort |
ghost-managed medicine big pharma’s invisible hands / |
publisher |
Mattering Press Mattering Press, |
publishDate |
2018 |
physical |
1 online resource (231 pages) : illustrations ; |
isbn |
0-9955277-7-6 0-9955277-8-4 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
illustrated |
Not Illustrated |
oclc_num |
1229912820 |
work_keys_str_mv |
AT sismondosergio ghostmanagedmedicinebigpharmasinvisiblehands |
status_str |
c |
ids_txt_mv |
(CKB)5590000000430781 (OCoLC)1229912820 (MdBmJHUP)muse95583 (oapen)https://directory.doabooks.org/handle/20.500.12854/48607 (EXLCZ)995590000000430781 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Ghost-Managed Medicine Big Pharma’s Invisible Hands / |
_version_ |
1796649061394153473 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03725cam a22004454a 4500</leader><controlfield tag="001">993544390204498</controlfield><controlfield tag="005">20230621141354.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr||||||||nn|n</controlfield><controlfield tag="008">180725s2018 enk o 00 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0-9955277-7-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5590000000430781</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1229912820</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MdBmJHUP)muse95583</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/48607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995590000000430781</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MdBmJHUP</subfield><subfield code="c">MdBmJHUP</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sismondo, Sergio,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ghost-Managed Medicine</subfield><subfield code="b">Big Pharma’s Invisible Hands /</subfield><subfield code="c">Sergio Sismondo.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Mattering Press</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Manchester :</subfield><subfield code="b">Mattering Press,</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©[2018]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (231 pages) : </subfield><subfield code="b">illustrations ;</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ghost-Managed Medicine by Sergio Sismondo explores a spectral side of medical knowledge, based in pharmaceutical industry tactics and practices. Hidden from the public view, the many invisible hands of the pharmaceutical industry and its agents channel streams of drug information and knowledge from contract research organizations (that extract data from experimental bodies) to publication planners (who produce ghostwritten medical journal articles) to key opinion leaders (who are sent out to educate physicians about drugs) to patient advocacy organizations (who ventriloquize views on diseases, treatments and regulations), and onward. The goal of this ‘assemblage marketing’ is to establish conditions that make specific diagnoses, prescriptions and purchases as obvious and frequent as possible. While staying in the shadows, companies create powerful markets in which increasing numbers of people become sick and the drugs largely sell themselves. Most agents for drug companies aim to tell the truth, but the truths they tell are drawn from streams of knowledge that have been fed, channeled and maintained by the companies at every possible opportunity. Especially because those companies have concentrated influence and narrow interests, consumers and others should be concerned about how epistemic power is distributed – or ‘political economies of knowledge’ – and not just about truth and falsity of medical knowledge. In pharmaceutical companies’ ideal worlds, medical research, education and marketing would be tightly fused. Doctors trying to educate themselves would turn to companies’ agents, such as researchers and educators sponsored to spread particular messages, local sales reps hired to change doctors’ behaviour, or journalists supplied with news stories. Ghost-Managed Medicine shows that the real world of medicine is not very far from the worlds that the companies want to create. Big Pharma’s many invisible hands are busy throughout medicine, and medicine changes as a result.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01060163</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00898905</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Marketing</subfield><subfield code="x">Moral and ethical aspects.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00898841</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Marketing</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Influence.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books. </subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">0-9955277-8-4</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-29 03:33:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2021-01-16 22:18:34 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337579600004498&Force_direct=true</subfield><subfield code="Z">5337579600004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337579600004498</subfield></datafield></record></collection> |